XSE-18873-11427
2 vaccinations
1 coded response
19 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 303 / GA
- Registered
- 2021-03-11
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
WK3-23775-83063
Child or adolescent in my care · Male · 2021-11-28
RL9-28418-07108
Child or adolescent in my care · Female · 2021-11-28
Timeline
-
2021-03-11
Registered in v-safe
-
2021-03-11
Dose 1 — Janssen/Johnson & Johnson
- 2021-03-11
- 2021-03-12
- 2021-03-13
- 2021-03-16
- 2021-03-20
- 2021-03-25
- 2021-04-01
- 2021-04-08
- 2021-04-21
- 2021-04-22
- 2021-06-10
- 2021-09-09
-
2021-10-22
Dose 2 — Moderna
- 2021-10-31
- 2021-11-05
- 2021-11-12
- 2021-11-21
- 2021-11-26
- 2021-12-03
-
2022-01-21
Survey response — 3 months, dose 2MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Covid positiveMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-11 | Janssen/Johnson & Johnson | |
| 2 | 2021-10-22 | Moderna | No |
Free text
Release 11 — 3 months, dose 2
Symptoms: Covid positive
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release